IDP-LLCb02

General Information


DRACP ID  DRACP01786

Peptide Name   IDP-LLCb02

Sequence  RRRRRRRSKAPKVVILSKALEYLQA

Sequence Length  25

UniProt ID  P12524  P10166 

PubChem CID  Not available

Origin  Synthetics

Type  Synthetic peptide

Classification

  

Active ACP Stapled Peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H187 Lung small cell carcinoma; Small cell lung cancer Carcinoma EC50≈7.5 μM MTT assay Not available Patent
NCI-H82 Lung small cell carcinoma; Small cell lung cancer Carcinoma EC50≈10 μM MTT assay Not available Patent
NCI-H510A Lung small cell carcinoma; Small cell lung cancer Carcinoma EC50≈15 μM MTT assay Not available Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01786

Helicity  Not available

Linear/Cyclic  Cyclic(stapled)

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  CPP2 corresponds to penetratine peptide.

Chiral  L



Physicochemical Information


Formula  C133H240N50O32

Absent amino acids  CDFGHMNTW

Common amino acids  R

Mass  347993

Pl  12.64

Basic residues  10

Acidic residues  1

Hydrophobic residues  9

Net charge  9

Boman Index  -10719

Hydrophobicity  -100

Aliphatic Index  97.6

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  62.08

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111511761A

Patent Title  Anticancer Peptides

Other Iinformation  Patent Application; Family: 8s / 8ex; Family Jurisdictions: CA, CN, US, AU, JP, EP, WO, KR; Legal Status: Pending; Application No: 201816635902; Filed: Jul 31, 2018; Published: May 21, 2020; Earliest Priority: Aug 1, 2017

Other Published ID  AU2018311129A1  CA3071601A1  CN111436200A  EP3661947A1  JP2020529429A  KR20200032730A  WO2019025432A1 




DRACP is developed by Dr.Zheng's team.